Whilst flatulence isnt always prominently listed in official prescribing information, it has been frequently reported by people using semaglutide (Wegovy) or tirzepatide (Mounjaro)particularly during the initial weeks of treatment
Since then, the popularity of similar weight-loss medications has surged, though supply and price are often barriers to treatment
17,499,500,501,502,503 Insulin resistance, a common occurrence in NASH patients, is a key driver of the diseases progression
Effects of Tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in subjects with type 2 diabetes
Low priority of obesity education leads to lack of medical students preparedness to effectively treat patients with obesity: results from the U.S